NASDAQ · Biotechnology
Tarsus Pharmaceuticals Inc (TARS)
$73.01
-6.00%
54
In band
Moving averages
SMA 200$67.79+7.70%
Company profile
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.
SectorHealthcare
IndustryBiotechnology
Market cap$3.78B
P/E ratioNone
EPS$-15.86
Beta0.331
Dividend yield0.00%
52-week high$91.53
52-week low$53.89
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
VKTX
Viking Therapeutics Inc
RSI 44
ATAI
ATAI Life Sciences N.V.
RSI 62
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
IBRX
ImmunityBio Inc
RSI 40
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
RSI alerts for TARS
An email when TARS closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:04 AM EST